405 Shares in Chemed Co. (NYSE:CHE) Acquired by Semanteon Capital Management LP

Semanteon Capital Management LP acquired a new position in Chemed Co. (NYSE:CHE) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 405 shares of the company’s stock, valued at approximately $237,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA acquired a new stake in shares of Chemed during the 3rd quarter valued at $47,655,000. International Assets Investment Management LLC acquired a new stake in shares of Chemed during the 4th quarter valued at $430,970,000. FMR LLC raised its holdings in shares of Chemed by 15.4% during the 3rd quarter. FMR LLC now owns 214,994 shares of the company’s stock valued at $111,732,000 after purchasing an additional 28,682 shares in the last quarter. TimesSquare Capital Management LLC raised its holdings in shares of Chemed by 15.3% during the 3rd quarter. TimesSquare Capital Management LLC now owns 203,510 shares of the company’s stock valued at $105,764,000 after purchasing an additional 27,029 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in shares of Chemed by 9.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 287,386 shares of the company’s stock valued at $149,355,000 after purchasing an additional 24,161 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity

In other Chemed news, VP Brian C. Judkins sold 11,158 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $645.00, for a total value of $7,196,910.00. Following the transaction, the vice president now directly owns 1,422 shares in the company, valued at $917,190. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other Chemed news, EVP Spencer S. Lee sold 2,000 shares of the business’s stock in a transaction dated Thursday, March 28th. The shares were sold at an average price of $641.65, for a total value of $1,283,300.00. Following the transaction, the executive vice president now directly owns 20,760 shares in the company, valued at $13,320,654. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, VP Brian C. Judkins sold 11,158 shares of the business’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total transaction of $7,196,910.00. Following the completion of the transaction, the vice president now directly owns 1,422 shares of the company’s stock, valued at $917,190. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,808 shares of company stock worth $10,184,531. Corporate insiders own 3.32% of the company’s stock.

Analyst Ratings Changes

CHE has been the topic of several recent analyst reports. Oppenheimer lifted their target price on shares of Chemed from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Thursday, February 29th. Royal Bank of Canada lifted their target price on shares of Chemed from $604.00 to $712.00 and gave the stock an “outperform” rating in a report on Monday, March 4th. Finally, StockNews.com downgraded shares of Chemed from a “buy” rating to a “hold” rating in a report on Friday.

Chemed Price Performance

NYSE CHE opened at $560.31 on Friday. The firm has a market capitalization of $8.47 billion, a price-to-earnings ratio of 30.16, a P/E/G ratio of 2.30 and a beta of 0.42. The company’s fifty day moving average is $623.29 and its two-hundred day moving average is $590.84. Chemed Co. has a 52-week low of $492.84 and a 52-week high of $654.62.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Wednesday, April 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.09 by ($0.41). Chemed had a return on equity of 30.52% and a net margin of 12.36%. The company had revenue of $589.23 million during the quarter, compared to analyst estimates of $587.18 million. As a group, sell-side analysts expect that Chemed Co. will post 21.99 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $1.60 annualized dividend and a dividend yield of 0.29%. Chemed’s dividend payout ratio (DPR) is currently 8.61%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.